172215-95-1 Usage
General Description
2-Acetamino-5-chloro-3-nitro benzotrifluoride is a chemical compound with the molecular formula C8H6ClF3N2O3. It is a derivative of benzotrifluoride and is often used in the production of pharmaceuticals and agrochemicals. 2-ACETAMINO-5-CHLORO-3-NITRO BENZOTRIFLUORIDE is commonly used as an intermediate in the synthesis of various drugs and is known for its wide range of pharmacological activities. It is also used as a building block in the development of new chemicals and has applications in the field of organic chemistry. Due to its potential health and environmental hazards, proper precautions should be taken when handling and storing this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 172215-95-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,2,1 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 172215-95:
(8*1)+(7*7)+(6*2)+(5*2)+(4*1)+(3*5)+(2*9)+(1*5)=121
121 % 10 = 1
So 172215-95-1 is a valid CAS Registry Number.
172215-95-1Relevant articles and documents
Glycine receptor antagonists and the use thereof
-
, (2008/06/13)
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia and treating psychosis are disclosed by administering to an animal in need of such treatment a compound having high affinity for the glycine binding site, lacking PCP side effects and which crosses the blood brain barrier of the animal. Also disclosed are novel 1,4-dihydroquinoxaline-2,3-diones, and pharmaceutical compositions thereof. Also disclosed are highly soluble ammonium salts of 1,4-dihydroquinoxaline-2,3-diones.